Your healthcare provider's oversight ensures appropriate dose transitions, monitors for adverse effects, and verifies that semaglutide addresses your original reasons for switching
instead, allow more time for natural adaptation
Oral semaglutide is made up of the same active ingredient as injectable GLP-1s, working to slow digestion, reduce appetite, regulate insulin sensitivity, and support weight loss
For smaller companies, or for non-pharmaceutical entities like hospital systems, pharmacy benefit managers, and specialty distributors that need patent intelligence to inform procurement strategy, building an internal function may not be cost-effective
You can return to normal activities instantly there is no healing time
You shouldn't take GLP-1s if you have type 1 diabetes, issues with your kidneys or pancreas, or if you are under 18, pregnant, or breastfeeding